Sickle Cell Disease is a genetic blood disorder characterised by the presence of sickle-shaped red blood cells, which can block blood flow, cause chronic pain, and lead to a host of physical ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...

Bengaluru, created an affordable, portable device for preliminary screening of Sickle Cell Disease (SCD). Led by Prof Gautam ...

Avascular necrosis in sickle cell disease can occur due to the impairment of blood supply to the bones, writes columnist.

A public health initiative was launched by the country’s premier research body, CSIR-CCMB to effectively combat sickle cell anaemia in Jharkhand. A large-scale screening for sickle cell anaemia will ...

Hyderabad, Apr 4: The Centre for Cellular and Molecular Biology (CCMB) has partnered with the Tata Steel Foundation (TSF) and the National Health Mission (NHM), Jharkhand, to launch a large-scale ...

Among the lesser-spotlighted roles of the immune system is how a particular T cell helps maintain homeostasis ... system play a dynamic role in the form of white fat known interchangeably ...

What we know: Sebastien Beauzile, 21, was born with sickle cell anemia, a hereditary blood disorder that can cause severe pain, tissue damage, and serious complications. But now, he has become ...

Scientists have discovered more than a dozen genes that regulate the production of fetal hemoglobin in people of African descent, which may be potential treatment targets for sickle cell disease (SCD) ...

This month, 21-year-old Sebastien Beauzile became the first man in New York history to be cured of sickle cell anemia, a genetic blood disorder, thanks to a new form of gene therapy. “ ...

A New York hospital has declared a patient cured of sickle-cell anemia, a debilitating genetic ... In January, GNN reported that base editing, another form of gene therapy that, like Lygenia ...

The potential target, the FLT1 gene, contributes to the production of a protein, fetal hemoglobin, whose presence is already known to improve the lifespan of people with sickle cell disease.